Evidence map›Paper›PMID 36299192›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2022

[ABC prognostic classification and MELD 3.0 and COSSH-ACLF Ⅱ prognostic evaluation in acute-on-chronic liver failure].

W S Liu, L J Shen, H Tian, Q H Zhai, D Z Li, F J Song, S J Xin, S L You

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
  2. [Focusing on timing selection and whole-course management of liver transplantation treatment for patients with acute-on-chronic liver failure].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

W S LiuLiver Disease Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
L J ShenLiver Disease Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
H TianLiver Disease Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
Q H ZhaiLiver Disease Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
D Z LiLiver Disease Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
F J SongLiver Disease Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
S J XinLiver Disease Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
S L YouLiver Disease Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
Chinese PLA General Hospital · CN

Funding

The 13th Five-Year National Science and Technology Major Project for Infectious Diseases 2017ZX10203201-004
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute-On-Chronic Liver FailureEnd Stage Liver DiseaseHumansPrognosisRetrospective StudiesSeverity of Illness Index

Identifiers

PMID36299192
PMCPMC12770579
OpenAlexW4307496587

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.